KANK1-NTRK2 fusion
|
Soft Tissue Sarcoma
|
KANK1-NTRK2 fusion
|
Soft Tissue Sarcoma
|
crizotinib Sensitive: C3 – Early Trials
|
crizotinib Sensitive: C3 – Early Trials
|
KANK1-NTRK2 fusion
|
Osteosarcoma
|
KANK1-NTRK2 fusion
|
Osteosarcoma
|
crizotinib Sensitive: C3 – Early Trials
|
crizotinib Sensitive: C3 – Early Trials
|